Most importantly, exports became the foundation of our development and the key to our success on the international stage from the start.

The Allergoff® brand was created in response to the growing needs of people suffering from allergies, asthma, and rhinitis. Its strength lays in the concept of tackling the causes, not just the symptoms of allergies – an approach that revolutionized thinking about prevention.

Thanks to this, Allergoff® quickly gained the trust of patients and doctors under the ARIA guidelines. To this day, it remains a symbol of conscious prevention, improving the quality of life for thousands of families in over 30 countries worldwide.

In 2008, Attracide® was launched – a liquid food bait with unprecedented effectiveness. Its legendary formula allowed it to capture all key markets across Europe, Russia, Africa, and South America.

Our new line of repellents with effectiveness lasting over 24 hours gained recognition in the markets of Switzerland, Slovakia, and the Czech Republic. Obtaining the BRC certificate gave us access to the shelves of major chains like Tesco, Sainsbury’s, Superdrug, and Boots. This step confirmed that ICB Pharma is a trustworthy partner in the most demanding markets.

The Pipi brand debuted between 1990-2012, quickly gaining recognition for its effectiveness against head lice. Its evolution resulted in the Nitolic brand – a family of specialized products that now holds the number one position in Poland for lice protection.

To date, over 7 million units have been sold in 36 countries, confirming the brand’s global success.

The opening of ICB Pharma’s new headquarters was an important symbol of dynamic growth and global ambition. The modern space fosters innovation, teamwork, and the development of R&D projects.

As a representative of the Agro industry, ICB Pharma contributed to the debate in the European Parliament during a series of meetings with MEPs. We discussed the most important challenges in modern agriculture, presenting innovative solutions based on science and practice.

This proves that our experience and knowledge matter at the highest decision-making level.

Born from a passion for music and the shared energy of our employees – the ICB Band was formed. The group blends various musical styles, showing that creativity and innovation at ICB Pharma extend far beyond the laboratories. The ICB Band has become a symbol of integration and the unique atmosphere within our company.

The launch of the Animal Health division opened a new chapter in ICB Pharma’s development. Its flagship product, Dergall®, gained recognition in over a dozen countries thanks to its effectiveness and innovative formula for protecting animal health. This was another step in building our global portfolio.

Annual integration trips, such as Get Lost and Lejdis, have become opportunities to build relationships, get to know each other, and strengthen collaboration. They are times of inspiration, joy, and shared memories that translate into the daily energy and success of our company.

Surpassing the threshold of 150 employees signals the scale and maturity of our organization. We are strengthening our teams, developing competencies and processes, and creating development programs.

This is truly our shared success – we thank everyone who co-creates the history of ICB Pharma.

We introduced the HACCP certificate for the Provecta® preparation, which allows its use in the presence of food articles without disrupting warehouse and back-office operations. Its fast-acting, innovative formula maintains hygiene and is simple to apply.

In 2024, our products debuted in one of the world’s most demanding markets—Japan. Through cooperation with an international partner possessing global experience, we proved that the innovativeness and quality of ICB Pharma’s products meet even the most stringent standards. This is a solid foundation for further expansion in the region.